Shareholder Vote

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 21, 2026 GENTEX CORPORATION (Exact name of registrant as specified in its charter) Michigan 0-10235 38-2030505 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 600 North Centennial Street Zeeland Michigan 49464 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: ( 616 ) 772-1800 _____________________________________________________________ (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): ☐     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.06 per share GNTX NASDAQ Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company     ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐      Section 5 – Corporate Governance and Management Item 5.07    Submission of Matters to a Vote of Security Holders. On May 21, 2026, the Company held its 2026 Annual Meeting of the Shareholders.  The matters listed and described briefly below were submitted to a vote of the shareholders through the solicitation of proxies. The proposals are described in detail in the Company's Proxy Statement filed on April 9, 2026.  The voting results are as follows: Election of Directors     The following individuals were elected to serve as directors of the Company to hold office for a one (1) year term expiring in 2027: Nominee Votes For Votes Withheld Broker Non-Votes Ms. Leslie Brown 158,128,540 14,512,140 17,860,451 Mr. Garth Deur 170,087,302 2,553,378 17,860,451 Mr. Steve Downing 171,724,331 916,349 17,860,451 Mr. John C. Kennedy 171,947,741 692,939 17,860,451 Dr. Billy Pink 171,917,659 723,021 17,860,451 Mr. Richard Schaum 162,704,794 9,935,886 17,860,451 Ms. Kathleen Starkoff 171,971,186 669,494 17,860,451 Mr. Brian Walker 171,034,722 1,605,958 17,860,451 Dr. Ling Zang 167,414,247 5,226,433 17,860,451 Proposal to Ratify the Appointment of Ernst & Young LLP as the Company's Auditors for the Fiscal Year Ending December 31, 2026     The shareholders did ratify the appointment of Ernst & Young LLP to serve as the Company's auditors for the fiscal year ending December 31, 2026: Votes For Votes Against Abstentions Broker Non-Votes 183,982,692 6,360,110 158,329 Proposal to Approve, on an Advisory Basis, the Compensation of the Company's Named Executive Officers     The shareholders did approve, on an advisory basis, the compensation of the Company's named executive officers: Votes For Votes Against Abstentions Broker Non-Votes 167,822,852 4,448,682 369,146 17,860,451 Proposal to Approve the Gentex Corporation 2026 Omnibus Incentive Plan     The shareholders did approve the Gentex Corporation 2026 Omnibus Incentive Plan: Votes For Votes Against Abstentions Broker Non-Votes 149,753,126 22,571,717 315,837 17,860,451 SIGNATURE     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Dated: May 26, 2026                            GENTEX CORPORATION                                     (Registrant)                                 By     /s/ Kevin Nash                                     Kevin Nash                                     Chief Financial Officer and                                     Vice President - Finance